June 2nd, 2022

4:00 pm

Room #2


Terry D. Box, MD

Blood-borne viral hepatitis infections are very common in the injecting drug user community. It is estimated that 40% of injection drug users have hepatitis C. 70% of new hepatitis C infections in the United States are linked to injection drug use. Addiction Medicine providers are key participants in screening for and linking to care / treating hepatitis C. To meet the World Health Organization goal of eliminating hepatitis C as a significant public health issues, Addiction Medicine providers will have to play a critical role. This presentation will review the epidemiology of HCV, the demographics of the current HCV epidemic and discuss screening and how to assess and treat those who are diagnosed with hepatitis C.

Once participants have completed this session, they will be able to:

(1) Trace the back-and-forth connections of substance use/abuse and communicable diseases; and,

(2) Identify the ‘gaps’ in systems designed to assist these individuals and how community partnerships and integrated care can positively impact these scenarios.


Self-Reporting Form 22.pdf

*Submission of the conference evaluation form indicates your completion of the entire program.

For tech support please click here.

Not seeing the content you were expecting during this livestream? Please double check the schedule to ensure that you’ve clicked on a session that is currently playing.